Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
6990Biotechnology
HK$437.80+0.97%As of Oct 29vs prior close
- Market cap
- $9.9B
- P/E (TTM)
- 434.7×
- P/E (FY1)
- 284.5×
- From 52W high
- −19.30%
- EPS (TTM)
- –
- Revenue (LTM)
- CN¥2.1B
- Net margin
- 7.25%
Nomior Score
61
Steady ProfileTop 25% of the scored universe
Growth82
Quality63
Value33
Momentum55
Resilience52
Growth
+36.79%revenue a year over 3 fiscal years
YE22 CN¥803.9MLTM CN¥2.1B
Connections
Revenue to profitYE25
The net loss was 19% of revenue, wider by 5 pts on a year.